Alaunos Therapeutics, Inc.
TCRT
$2.63
-$0.05-1.87%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -82.00% | -85.91% | -86.55% | -82.36% | -84.48% |
| Total Receivables | 400.00% | -- | 0.00% | -- | -75.00% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -24.52% | 101.84% | 383.81% | 152.13% | 175.09% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -66.65% | -72.41% | -75.09% | -84.19% | -84.64% |
|
|
|||||
| Total Current Assets | -66.65% | -72.41% | -75.09% | -84.19% | -84.64% |
| Net Property, Plant & Equipment | -100.00% | -- | -- | -- | -99.98% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -66.66% | -81.74% | -83.25% | -87.59% | -87.28% |
|
|
|||||
| Total Accounts Payable | -16.23% | -64.71% | -75.32% | -56.74% | -55.65% |
| Total Accrued Expenses | -86.87% | -88.02% | -83.24% | -84.39% | -75.43% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | -64.62% | -82.34% | -82.05% | -92.73% | -91.91% |
|
|
|||||
| Total Current Liabilities | -64.62% | -82.34% | -82.05% | -92.73% | -91.91% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -64.62% | -85.09% | -85.55% | -93.52% | -92.59% |
|
|
|||||
| Common Stock & APIC | 0.05% | 0.07% | 0.14% | 0.22% | 0.31% |
| Retained Earnings | -0.51% | -1.30% | -2.13% | -3.01% | -3.99% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -67.29% | -80.40% | -82.58% | -83.74% | -83.64% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -67.29% | -80.40% | -82.58% | -83.74% | -83.64% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -67.29% | -80.40% | -82.58% | -83.74% | -83.64% |
|
|
|||||